Tamiflu and strong franc weigh down sales at Roche

14th October 2010, Comments 0 comments

Pharma company Roche announces "solid sales growth" on Thursday, but the groups overall figures are dragged down by a slump in Tamiflu, the drug used to tackle swine flu. Accounted for in francs the firms sales drop compared with last year. The beefy currency impacts negatively on other leading Swiss firms, such as Nestl, as more companies prepare to release third quarter sales data.

0 Comments To This Article